Appointment of Chief Financial Officer (CFO)
Pursuant to Regulation 30 of the Securities and Exchange Board of India [Listing Obligations and Disclosure Requirements], 2015, we inform that Audit Committee/Board of Directors have in their meetings both held on February 7, 2018 appointed Mr. Umesh Parikh as a Chief Financial Officer of the Company with effect from today i.e. February 7, 2018.... Un-Audited Financial Results For The Quarter/Nine Months Ended December 31, 2017
Please find attached herewith the un-audited financial results for the quarter / nine months ended on December 31, 2017, reviewed by the Audit Committee and taken on record by the Board of Directors today i.e. February 7, 2018 pursuant to Regulation No. 33[2][a] of the SEBI [Listing Obligations and Disclosure Requirements] Regulations, 2015 along with Limited Review Reports [Standalone and Consolidated] and Press Release. Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI [Listing Obligations and Disclosure Requirements] Regulations, 2015, we hereby inform that the Company has planned investor interaction through a teleconference call at 5.00 p.m. on Wednesday, February 7, 2018 for Q3 FY 18 post results Q&A; session. Skin care or functional food? Zydus Wellness eyes acquisitions in FY19
With Rs 4,897 mn cash in balance sheet and a 94 per cent category share in artificial sweeteners, the company is eyeing the inorganic route to propel growth Shareholding for the Period Ended December 31, 2017
Zydus Wellness Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here Notice For The Meeting Of The Board Of Directors / Closure Of Trading Window
We hereby inform that a meeting of the Board of Directors of the Company will be held on Wednesday, February 7, 2018 to consider apart from other agenda items to approve the unaudited financial results for the quarter / nine months ended on December 31, 2017. Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI [Prohibition of Insider Trading] Regulations, 2015 as amended from time to time,... Statement Of Investors' Complaints As On December 31, 2017
In compliance with the provisions of Regulation 13[3] of the SEBI [Listing Obligations and Disclosure Requirements] Regulations, 2015, the status of Investor Complaints as on December 31, 2017 is as per attached letter. Zydus Pharmaceuticals receives USFDA nod to market OCD treatment drug
Zydus Pharmaceuticals Inc is a wholly-owned subsidiary of Cadila Healthcare Ltd Zydus Healthcare moves India marketing operations to Mumbai
Zydus Healthcare is a wholly owned subsidiary of Cadila Healthcare Zydus Wellness CFO resigns
Zydus Wellness today said its Chief Financial Officer Amit B Jain has resigned from the company. Amit B Jain has tendered his resignation as the Chief Financial Officer (Key Managerial Personnel)...